Brink Biologics Announces Research License Agreement?with?Worcester Polytechnic Institute?for Use of NantKwest?s NK-92??Cells

SAN DIEGO–(BUSINESS WIRE)–Brink Biologics, Inc., a?NantKwest, Inc. (Nasdaq:NK) affiliate who serves as exclusively-licensed distributor of NantKwest?s proprietary NK-92? natural killer cells, offers a variety of research grade aNK? and haNK? cell lines for non-clinical laboratory use in discovery, translational and developmental research and lot release testing for commercial products ranging from monoclonal antibodies, bi-specific biologics, cytokines and other bioactive products. Using livi